Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-09 @ 10:31 AM
Study NCT ID:
NCT00977912
Status:
TERMINATED
Last Update Posted:
2013-11-25
First Post:
2009-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies
Sponsor:
Société des Produits Nestlé (SPN)
Organization:
Study Overview
Official Title:
Prevention of NEC in Preterm Infants With B. Lactis
Status:
TERMINATED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the trial is to demonstrate the effect of B. lactis in reducing the incidence of Necrotizing Enterocolitis (NEC) compared to placebo in preterm infants.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: